Form 4: Glaukos COO Sells Shares for Tax Obligations
Insider Transaction Report
Glaukos Corporation's President and COO, Joseph E. Gilliam, reported the sale of shares to cover tax withholdings related to restricted stock unit vesting.
Summary
- Joseph E. Gilliam, President & COO of Glaukos Corporation (GKOS), reported transactions involving the disposition of common stock.
- On March 23, 2026, 2,804 shares were disposed of at a price of $106.84 per share, related to tax withholding obligations from restricted stock units granted on March 22, 2023.
- On March 24, 2026, a total of 12,314 shares (4,926 and 7,388 shares) were disposed of at a price of $105.23 per share, related to tax withholding obligations from restricted stock units granted on March 24, 2022.
- Following these transactions, Joseph E. Gilliam beneficially owns 72,540 shares of common stock.
- The beneficial ownership includes 48,787, 39,725, and 26,133 restricted stock units that have not yet vested or been delivered.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as it represents a routine, non-discretionary transaction for tax purposes related to executive equity compensation, with no direct impact on the company's operational or financial performance.
Industry Context
StockSavvy.ai notes that these transactions are routine for executives receiving equity compensation, as shares are commonly withheld to cover tax liabilities upon the vesting of restricted stock units. This is a standard mechanism in executive compensation plans across various industries, particularly in the medical technology sector where Glaukos operates.
Comparison to Industry Standards
- The practice of withholding shares for tax obligations upon RSU vesting is a common and standard procedure for executive compensation across publicly traded companies, including those in the medical device and ophthalmology sectors like Glaukos.
- Comparable companies such as Alcon (ALC), Bausch + Lomb (BLCO), and Johnson & Johnson (JNJ) with significant medical device divisions, frequently report similar Form 4 filings for their executives, reflecting the standard operational aspects of equity-based compensation.
Stakeholder Impact
- Shareholders: Minimal direct impact, as these are routine tax-related transactions by an insider and do not reflect a discretionary sale or change in management's confidence in the company.
- Employees: No direct impact.
Key Dates
| Date | Description |
|---|---|
| 2022-03-24 | Date of restricted stock units grant, which vested and led to tax withholding transactions on March 24, 2026. |
| 2023-03-22 | Date of restricted stock units grant, which vested and led to tax withholding transactions on March 23, 2026. |
| 2026-03-23 | Transaction date for the disposition of 2,804 shares for tax withholding. |
| 2026-03-24 | Transaction date for the disposition of 4,926 and 7,388 shares for tax withholding. |
| 2026-03-25 | Date the Form 4 was signed by Diana Scherer, Attorney-in-Fact. |
Keywords
Glaukos Corporation, GKOS, Joseph E Gilliam, Form 4, Insider Transaction, Restricted Stock Units, Tax Withholding, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.